Invention Grant
US08530517B2 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
失效
维甲酸衍生物具有细胞毒性和/或抗血管生成特性
- Patent Title: Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
- Patent Title (中): 维甲酸衍生物具有细胞毒性和/或抗血管生成特性
-
Application No.: US13141831Application Date: 2009-12-21
-
Publication No.: US08530517B2Publication Date: 2013-09-10
- Inventor: Walter Cabri , Giuseppe Giannini , Gianfranco Battistuzzi , Domenico Alloatti , Claudio Pisano , Sabrina Dallavalle , Tiziana Brunetti
- Applicant: Walter Cabri , Giuseppe Giannini , Gianfranco Battistuzzi , Domenico Alloatti , Claudio Pisano , Sabrina Dallavalle , Tiziana Brunetti
- Applicant Address: IT Rome
- Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Current Assignee Address: IT Rome
- Agency: Vedder Price P.C.
- Agent Thomas J. Kowalski; Samuel Megerditchian
- Priority: EP08172883 20081224
- International Application: PCT/EP2009/067667 WO 20091221
- International Announcement: WO03/011808 WO 20030213
- Main IPC: A61K31/192
- IPC: A61K31/192 ; C07C235/32
Abstract:
The present invention relates to new retinoid derivatives of formula I and to pharmaceutical compositions containing them for the treatment of patients affected by pathologies such as arthritic conditions, tumors, metastatic cancer, diabetic retinopathy, psoriasis, chronic inflammatory diseases or atherosclerosis.
Public/Granted literature
- US20110312965A1 RETINOID DERIVATIVES ENDOWED WITH CYTOTOXIC AND/OR ANTIANGIOGENIC PROPERTIES Public/Granted day:2011-12-22
Information query
IPC分类:
